Tokyo, Nov. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062875) titled 'Maternal Immunosuppressive Therapy and Neonatal Transient Immunodeficiency Study' on Nov. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Tohoku University
Condition:
Condition - pregnant women
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - This study aims to elucidate the immunological characteristics from birth through the neonatal period in infants born to mothers undergoing immunosuppressive therapy, as well as the incidence of complications suspected to be associated with postnatal immunosuppression. The study will focus on an evaluation of TREC an...